AzTrials
AzTrials

Cerebral PalsyNCT07921069

Sensory Integration Therapy vs Conventional Physical Therapy in Children With Mixed Cerebral Palsy

A study testing Sensory Integration Therapy and Conventional Physical Therapy in people with Cerebral Palsy, run by Riphah International University at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The study aims to compare Sensory Integration Therapy (SIT) with Conventional Physical Therapy (CPT) for improving gross motor function in children aged 4-10 years with mixed cerebral palsy. This randomized controlled trial plans to include 50 participants divided into two groups. Read more about this study

Who is it for?
Ages 4 to 10 years
Conditions the study is for
Cerebral Palsy
What is being tested?
Sensory Integration Therapy and Conventional Physical Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 sitePakistan
Study dates
21 Oct 2026to Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children diagnosed with mixed cerebral palsy.
  • Medically stable children who are able to participate in the intervention sessions.
  • Parent or legal guardian willing to provide written informed consent.

Who cannot join

  • Children with severe cognitive or visual impairments.
  • Children with uncontrolled seizures.
  • Children with orthopedic deformities requiring surgery.
  • Children who have received botulinum toxin injections within the previous six months.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Salim Khan Dr. Salim Khan, MS contact

091-5822509

salim.khan@akbarkare.org

Pakistan1 site, 1 recruiting
  • Akhbar kare center Peshawar

    Peshawar, Kpk, 25000

    091-5822509

    Recruiting

Other trials in Pakistan

About this study

Official title: Sensory Integration Therapy Compared With Conventional Physical Therapy for Gross Motor Function in Children With Mixed Cerebral Palsy: A Randomized Controlled Trial

The study aims to compare Sensory Integration Therapy (SIT) with Conventional Physical Therapy (CPT) for improving gross motor function in children aged 4-10 years with mixed cerebral palsy. This randomized controlled trial plans to include 50 participants divided into two groups. Group A will receive Sensory Integration Therapy, while Group B will receive Conventional Physical Therapy over a 12-week intervention period. Outcomes will be assessed using the Gross Motor Function Measure (GMFM-88), Short Sensory Profile (SSP), and Parent-Reported Functional Independence \& Daily Activity Performance (PR-FADAP). Data will be analyzed using SPSS version 26, with statistical significance set at p < 0.05. The study is expected to determine which intervention is more effective in improving gross motor function and sensory processing in children with mixed cerebral palsy.

Read the detailed description

This randomized controlled trial aims to determine the effectiveness of Sensory Integration Therapy (SIT) compared with Conventional Physical Therapy (CPT) in improving gross motor function in children aged 4-10 years with mixed cerebral palsy. A total of 50 participants will be randomly allocated to two groups and receive their respective interventions for 12 weeks. Outcomes will be assessed using the Gross Motor Function Measure (GMFM-88), Short Sensory Profile (SSP), and PR-FADAP questionnaire. Data will be analyzed using SPSS version 26 to compare changes between the two groups.

Conditions
Cerebral Palsy
Being tested
Sensory Integration Therapy, Conventional Physical Therapy
Keywords
Sensory Integration Therapy, Conventional Physical Therapy, Mixed Cerebral Palsy, Gross Motor Function, Gross Motor Function Measure (GMFM-88), Short Sensory Profile (SSP), Pediatric Rehabilitation
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sensory Integration TherapyBehavioural

    A 12-week sensory-motor intervention involving vestibular, tactile, and proprioceptive stimulation, balance and coordination activities, visual-motor tasks, graded multisensory challenges, and functional activities. The protocol specifies sessions of 60 minutes, with frequency progressing from 3 to 5 sessions per week.

  • Conventional Physical TherapyBehavioural

    A 12-week conventional physical therapy program involving stretching, range-of-motion exercises, muscle strengthening, postural alignment, balance training, gait training, transitional movements, stair climbing, endurance activities, and functional task practice. The protocol specifies sessions of 60 minutes, with frequency progressing from 3 to 5 sessions per week.

Study groups in NCT07921069
Study groupRoleWhat they receive
Sensory Integration Therapy (SIT)ExperimentalParticipants will receive Sensory Integration Therapy for 12 weeks, involving graded vestibular, tactile, and proprioceptive stimulation, balance and coordination activities, visual-motor tasks, multisensory play, and functional activities to improve gross motor function and sensory processing.
Receives: Behavioral: Sensory Integration Therapy
Conventional Physical TherapyActive comparatorParticipants will receive conventional physical therapy for 12 weeks, including stretching, range-of-motion exercises, muscle strengthening, postural control, static and dynamic balance training, gait training, transitional movements, stair climbing, and functional task practice to improve gross motor function.
Receives: Behavioral: Conventional Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Gross Motor Function Measure-88 (GMFM-88) Score

    Gross motor function will be assessed using the Gross Motor Function Measure-88 (GMFM-88), a standardized tool for evaluating motor function in children with cerebral palsy. Changes in scores will be compared between the Sensory Integration Therapy group and the Conventional Physical Therapy group.

    Measured: Baseline and immediately after the 12-week intervention.

Secondary outcomes (2)
  1. Change in Short Sensory Profile (SSP) Score

    Sensory processing behaviors will be assessed using the Short Sensory Profile (SSP). Changes in scores from baseline to post-intervention will be compared between the two treatment groups.

    Measured: Baseline and immediately after the 12-week intervention.

  2. Change in Functional Independence and Daily Activity Performance

    Functional independence and daily activity performance will be assessed using the Parent-Reported Functional Independence \& Daily Activity Performance (PR-FADAP) questionnaire, as specified in the study protocol. Changes in scores will be compared between the two treatment groups.

    Measured: Baseline and immediately after the 12-week intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2026
  2. Study start21 Oct 2026
  3. Primary completionApr 2027 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07921069
Sponsor's protocol ID
Laiba Awan
Status last verified
Nov 2026
First submitted
2 Nov 2026
Last updated
6 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D; Executive Committee for the Definition of Cerebral Palsy. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005 Aug;47(8):571-6. doi: 10.1017/s001216220500112x.

    PubMed 16108461
  • Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil. 2006 Feb 28;28(4):183-91. doi: 10.1080/09638280500158422.

    PubMed 16467053
  • Khandaker G, Muhit M, Karim T, Smithers-Sheedy H, Novak I, Jones C, Badawi N. Epidemiology of cerebral palsy in Bangladesh: a population-based surveillance study. Dev Med Child Neurol. 2019 May;61(5):601-609. doi: 10.1111/dmcn.14013. Epub 2018 Nov 5.

    PubMed 30394528
  • Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb;109:8-14.

    PubMed 17370477

Questions about this trial

What is this clinical trial studying?

A study testing Sensory Integration Therapy and Conventional Physical Therapy in people with Cerebral Palsy, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Salim Khan Dr. Salim Khan, MS (091-5822509, salim.khan@akbarkare.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Gross Motor Function Measure-88 (GMFM-88) Score (time frame: Baseline and immediately after the 12-week intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07921069, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in